Beijing/Manila/Geneva, 23 August 2022 – The World Health Organization (WHO) today ranked China’s vaccine regulatory system at a functional level of maturity according to WHO’s global classification system for national medical products regulatory authorities. This means that China has a stable, well-functioning and integrated regulatory system to ensure the quality, safety, and effectiveness of vaccines that are manufactured, imported or distributed in the country.
WHO confirmed the country’s attainment of maturity level three (ML3)—the third of four levels in the WHO’s classification. Maturity level four (ML4) is the highest.
“Congratulations to the People’s Republic of China for achieving maturity level 3 for their vaccine regulation system. This is a significant step for the global supply of vaccines because of China’s role as a manufacturer, as well as being an important step for public health in China. It will bring more quality-assured vaccines to save lives around the world. My appreciation goes to the National Medical Products Administration, affiliated national institutions and provincial authorities who